Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Oat and chickpea drink may boost brain health in seniors

NCT ID NCT06353984

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a drink made from oats and chickpeas can improve thinking and brain activity in healthy adults aged 70 and older. Over 9 weeks, 114 participants will consume the drink daily. Researchers will use brain scans and blood tests to measure changes in brain function, inflammation, and overall health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A drinkable food product made from bioprocessed oats and chickpeas
What this could lead to
If it works, this could point toward a simple dietary supplement that supports brain health and healthy aging in older adults.
What could go wrong
This is an early exploratory study with only 114 participants, so results may not be conclusive. The effect on thinking or brain activity may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 114 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2024

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent prior to any study-related procedure * Age 70 years and above * Normal weight to overweight at the screening defined as BMI range 18.5-31.9 * Willing to abstain from regular consumption of medication known to alter gastrointestinal function or inflammatory status after being included and during the study * Willingness to pick up study products and eat the products according to the instructions each day Exclusion Criteria: * Diagnosis of type 1 and/or type 2 diabetes * Immobile (defined as the inability to participate in all study-related procedures) * History of complicated gastrointestinal surgery * Diagnosed inflammatory bowel disease (IBD) * Current diagnosis of psychiatric disease/s or syndromes * Current diagnosis of neurodegenerative disease * Systemic use of antibiotics and/or steroid medication in the last 4 months prior to inclusion * Use of probiotics, prebiotics, fermented foods, kombucha, and any other product known to modulate gut microbiota composition in the last 2 months prior to inclusion * Use of any non-steroidal anti-inflammatory drug (NSAID) more than 3 times a week in the last 2 months prior to inclusion * Use of statins * Consumption of any NSAID within 7 days of study start * Any condition which could interfere with intestinal barrier function (e.g. gluten sensitivity, lactose intolerance, celiac disease, IBS, IBD) as decided by the principal investigators' discretion * Vegetarian diet * Allergy to ingredients included in either investigational or reference products * Regular smoking, use of snuff, nicotine, or e-cigarette use * Drinking more than 9 standard cups of alcohol per week and/or more than 3 standard cups of alcohol per occasion * Regular use, for more than three times a week for the last 2 months and/or 7 days prior to inclusion, of medications which according to the principal investigator can have an anti-inflammatory effect or affect in any way the intestinal barrier function or have an impact on the study analysis (such as laxatives, anti-diarrheal, anti-cholinergic, etc.) * After being included in the study, starting any medication or treatment that could potentially influence the study participation and/or study analysis * Cerebral bleeding or history of cerebral bleeding * Claustrophobia * In operated apparatus (e.g., pacemaker) * Aneurysm clips or shunts in the head * Grenade-splinter or metal-splinter in the body (e.g., eyes) * Metal or electrodes in the body (e.g., temp-catheter, aorta stent, cochlea implant) * Comprehensive tooth-implants or prosthesis * Operated in the head or in the heart * Swallowed a video-capsule * Left-handed * Severe vision impairments * Being highly physically active, competing as a master athlete and/or partaking in physical demanding training more than four times per week, extreme exercising * Any other reason the investigator feels the subject is not suitable for participation in this aspect of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive function are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Örebro University

    Örebro, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.